調査レポート | • レポートコード：GIR-2104Z00371 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、成人用ワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。成人用ワクチンの種類別市場規模（インフルエンザ、子宮頸がん、帯状疱疹、肺炎球菌、髄膜炎球菌、MMRV、肝炎、DTP、旅行・その他）、用途別市場規模（病院、医療センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・成人用ワクチンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Valeo、Continental、Magna International、Hitachi Automotive、Fujitsu、Ficosa ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：インフルエンザ、子宮頸がん、帯状疱疹、肺炎球菌、髄膜炎球菌、MMRV、肝炎、DTP、旅行・その他 ・用途別分析2016年-2026年：病院、医療センター、その他 ・成人用ワクチンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・成人用ワクチンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・成人用ワクチンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・成人用ワクチンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・成人用ワクチンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Adult Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Adult Vaccine size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Adult Vaccine market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Adult Vaccine market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Influenza
Cervical Cancer
Zoster Shingles
Pneumococcal
Meningococcal
MMRV
Hepatitis
DTP
Travel and Miscellaneous
Market segment by Application can be divided into
Hospitals
Medical Care Centers
Other
The key market players for global Adult Vaccine market are listed below:
GlaxoSmithKline
Sanofi Pasteur
Merck
Novartis
Pfizer
BioCSL (Seqirus)
Protein Sciences
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Adult Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Adult Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Influenza
1.2.3 Cervical Cancer
1.2.4 Zoster Shingles
1.2.5 Pneumococcal
1.2.6 Meningococcal
1.2.7 MMRV
1.2.8 Hepatitis
1.2.9 DTP
1.2.10 Travel and Miscellaneous
1.3 Market Analysis by Application
1.3.1 Overview: Global Adult Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Medical Care Centers
1.3.4 Other
1.4 Global Adult Vaccine Market Size & Forecast
1.4.1 Global Adult Vaccine Sales in Value (2016-2026))
1.4.2 Global Adult Vaccine Sales in Volume (2016-2026)
1.4.3 Global Adult Vaccine Price by Type (2016-2026) & (USD/MT)
1.5 Global Adult Vaccine Production Capacity Analysis
1.5.1 Global Adult Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Adult Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Adult Vaccine Market Drivers
1.6.2 Adult Vaccine Market Restraints
1.6.3 Adult Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Adult Vaccine Product and Services
2.1.4 GlaxoSmithKline Adult Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sanofi Pasteur
2.2.1 Sanofi Pasteur Details
2.2.2 Sanofi Pasteur Major Business
2.2.3 Sanofi Pasteur Adult Vaccine Product and Services
2.2.4 Sanofi Pasteur Adult Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Adult Vaccine Product and Services
2.3.4 Merck Adult Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Adult Vaccine Product and Services
2.4.4 Novartis Adult Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Adult Vaccine Product and Services
2.5.4 Pfizer Adult Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 BioCSL (Seqirus)
2.6.1 BioCSL (Seqirus) Details
2.6.2 BioCSL (Seqirus) Major Business
2.6.3 BioCSL (Seqirus) Adult Vaccine Product and Services
2.6.4 BioCSL (Seqirus) Adult Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Protein Sciences
2.7.1 Protein Sciences Details
2.7.2 Protein Sciences Major Business
2.7.3 Protein Sciences Adult Vaccine Product and Services
2.7.4 Protein Sciences Adult Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Adult Vaccine Sales by Manufacturer
3.1 Global Adult Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Adult Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Adult Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Adult Vaccine Manufacturer Market Share
3.4.2 Top 6 Adult Vaccine Manufacturer Market Share
3.5 Global Adult Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Adult Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Adult Vaccine Market Size by Region
4.1.1 Global Adult Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Adult Vaccine Revenue by Region (2016-2026)
4.2 North America Adult Vaccine Revenue (2016-2026)
4.3 Europe Adult Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Adult Vaccine Revenue (2016-2026)
4.5 South America Adult Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Adult Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Adult Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Adult Vaccine Revenue by Type (2016-2026)
5.3 Global Adult Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Adult Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Adult Vaccine Revenue by Application (2016-2026)
6.3 Global Adult Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Adult Vaccine Sales by Type (2016-2026)
7.2 North America Adult Vaccine Sales by Application (2016-2026)
7.3 North America Adult Vaccine Market Size by Country
7.3.1 North America Adult Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Adult Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Adult Vaccine Sales by Type (2016-2026)
8.2 Europe Adult Vaccine Sales by Application (2016-2026)
8.3 Europe Adult Vaccine Market Size by Country
8.3.1 Europe Adult Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Adult Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Adult Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Adult Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Adult Vaccine Market Size by Region
9.3.1 Asia-Pacific Adult Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Adult Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Adult Vaccine Sales by Type (2016-2026)
10.2 South America Adult Vaccine Sales by Application (2016-2026)
10.3 South America Adult Vaccine Market Size by Country
10.3.1 South America Adult Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Adult Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Adult Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Adult Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Adult Vaccine Market Size by Country
11.3.1 Middle East & Africa Adult Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Adult Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Adult Vaccine Typical Distributors
12.3 Adult Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Adult Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Adult Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Adult Vaccine Product and Services
Table 6. GlaxoSmithKline Adult Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Pasteur Major Business
Table 9. Sanofi Pasteur Adult Vaccine Product and Services
Table 10. Sanofi Pasteur Adult Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Adult Vaccine Product and Services
Table 14. Merck Adult Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Adult Vaccine Product and Services
Table 18. Novartis Adult Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Adult Vaccine Product and Services
Table 22. Pfizer Adult Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. BioCSL (Seqirus) Basic Information, Manufacturing Base and Competitors
Table 24. BioCSL (Seqirus) Major Business
Table 25. BioCSL (Seqirus) Adult Vaccine Product and Services
Table 26. BioCSL (Seqirus) Adult Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Protein Sciences Basic Information, Manufacturing Base and Competitors
Table 28. Protein Sciences Major Business
Table 29. Protein Sciences Adult Vaccine Product and Services
Table 30. Protein Sciences Adult Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Global Adult Vaccine Sales by Manufacturer (2019-2021e) & (K MT)
Table 32. Global Adult Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 33. Market Position of Manufacturers in Adult Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 34. Global Adult Vaccine Production Capacity by Company, (K MT): 2020 VS 2021
Table 35. Head Office and Adult Vaccine Production Site of Key Manufacturer
Table 36. Global Adult Vaccine Sales by Region (2016-2021e) & (K MT)
Table 37. Global Adult Vaccine Sales by Region (2021-2026) & (K MT)
Table 38. Global Adult Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 39. Global Adult Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 40. Global Adult Vaccine Sales by Type (2016-2021e) & (K MT)
Table 41. Global Adult Vaccine Sales by Type (2021-2026) & (K MT)
Table 42. Global Adult Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 43. Global Adult Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 44. Global Adult Vaccine Price by Type (2016-2021e) & (USD/MT)
Table 45. Global Adult Vaccine Price by Type (2021-2026) & (USD/MT)
Table 46. Global Adult Vaccine Sales by Application (2016-2021e) & (K MT)
Table 47. Global Adult Vaccine Sales by Application (2021-2026) & (K MT)
Table 48. Global Adult Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 49. Global Adult Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 50. Global Adult Vaccine Price by Application (2016-2021e) & (USD/MT)
Table 51. Global Adult Vaccine Price by Application (2021-2026) & (USD/MT)
Table 52. North America Adult Vaccine Sales by Country (2016-2021e) & (K MT)
Table 53. North America Adult Vaccine Sales by Country (2021-2026) & (K MT)
Table 54. North America Adult Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 55. North America Adult Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 56. North America Adult Vaccine Sales by Type (2016-2021e) & (K MT)
Table 57. North America Adult Vaccine Sales by Type (2021-2026) & (K MT)
Table 58. North America Adult Vaccine Sales by Application (2016-2021e) & (K MT)
Table 59. North America Adult Vaccine Sales by Application (2021-2026) & (K MT)
Table 60. Europe Adult Vaccine Sales by Country (2016-2021e) & (K MT)
Table 61. Europe Adult Vaccine Sales by Country (2021-2026) & (K MT)
Table 62. Europe Adult Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 63. Europe Adult Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 64. Europe Adult Vaccine Sales by Type (2016-2021e) & (K MT)
Table 65. Europe Adult Vaccine Sales by Type (2021-2026) & (K MT)
Table 66. Europe Adult Vaccine Sales by Application (2016-2021e) & (K MT)
Table 67. Europe Adult Vaccine Sales by Application (2021-2026) & (K MT)
Table 68. Asia-Pacific Adult Vaccine Sales by Region (2016-2021e) & (K MT)
Table 69. Asia-Pacific Adult Vaccine Sales by Region (2021-2026) & (K MT)
Table 70. Asia-Pacific Adult Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 71. Asia-Pacific Adult Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Adult Vaccine Sales by Type (2016-2021e) & (K MT)
Table 73. Asia-Pacific Adult Vaccine Sales by Type (2021-2026) & (K MT)
Table 74. Asia-Pacific Adult Vaccine Sales by Application (2016-2021e) & (K MT)
Table 75. Asia-Pacific Adult Vaccine Sales by Application (2021-2026) & (K MT)
Table 76. South America Adult Vaccine Sales by Country (2016-2021e) & (K MT)
Table 77. South America Adult Vaccine Sales by Country (2021-2026) & (K MT)
Table 78. South America Adult Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 79. South America Adult Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 80. South America Adult Vaccine Sales by Type (2016-2021e) & (K MT)
Table 81. South America Adult Vaccine Sales by Type (2021-2026) & (K MT)
Table 82. South America Adult Vaccine Sales by Application (2016-2021e) & (K MT)
Table 83. South America Adult Vaccine Sales by Application (2021-2026) & (K MT)
Table 84. Middle East & Africa Adult Vaccine Sales by Country (2016-2021e) & (K MT)
Table 85. Middle East & Africa Adult Vaccine Sales by Country (2021-2026) & (K MT)
Table 86. Middle East & Africa Adult Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 87. Middle East & Africa Adult Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 88. Middle East & Africa Adult Vaccine Sales by Type (2016-2021e) & (K MT)
Table 89. Middle East & Africa Adult Vaccine Sales by Type (2021-2026) & (K MT)
Table 90. Middle East & Africa Adult Vaccine Sales by Application (2016-2021e) & (K MT)
Table 91. Middle East & Africa Adult Vaccine Sales by Application (2021-2026) & (K MT)
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Adult Vaccine Typical Distributors
Table 95. Adult Vaccine Typical Customers
List of Figures
Figure 1. Adult Vaccine Picture
Figure 2. Global Adult Vaccine Sales Market Share by Type in 2020
Figure 3. Influenza
Figure 4. Cervical Cancer
Figure 5. Zoster Shingles
Figure 6. Pneumococcal
Figure 7. Meningococcal
Figure 8. MMRV
Figure 9. Hepatitis
Figure 10. DTP
Figure 11. Travel and Miscellaneous
Figure 12. Global Adult Vaccine Sales Market Share by Application in 2020
Figure 13. Hospitals
Figure 14. Medical Care Centers
Figure 15. Other
Figure 16. Global Adult Vaccine Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 17. Global Adult Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 18. United States Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Canada Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Mexico Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Germany Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. France Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. United Kingdom Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Russia Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Italy Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. China Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Japan Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Korea Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. India Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Southeast Asia Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Australia Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Brazil Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Egypt Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Saudi Arabia Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. South Africa Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Turkey Adult Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 37. Global Adult Vaccine Sales (2016-2026) & (K MT)
Figure 38. Global Adult Vaccine Production Capacity (2016-2026) & (K MT)
Figure 39. Global Adult Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 40. Adult Vaccine Market Drivers
Figure 41. Adult Vaccine Market Restraints
Figure 42. Adult Vaccine Market Trends
Figure 43. Global Adult Vaccine Sales Market Share by Manufacturer in 2020
Figure 44. Global Adult Vaccine Revenue Market Share by Manufacturer in 2020
Figure 45. Adult Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 46. Top 3 Adult Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 47. Top 6 Adult Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 48. Global Adult Vaccine Sales Market Share by Region (2016-2026)
Figure 49. Global Adult Vaccine Revenue Market Share by Region (2016-2026)
Figure 50. North America Adult Vaccine Revenue (2016-2026) & (USD Million)
Figure 51. Europe Adult Vaccine Revenue (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Adult Vaccine Revenue (2016-2026) & (USD Million)
Figure 53. South America Adult Vaccine Revenue (2016-2026) & (USD Million)
Figure 54. Middle East & Africa Adult Vaccine Revenue (2016-2026) & (USD Million)
Figure 55. Global Adult Vaccine Sales Market Share by Type (2016-2026)
Figure 56. Global Adult Vaccine Revenue Market Share by Type (2016-2026)
Figure 57. Global Adult Vaccine Price by Type (2016-2026) & (USD/MT)
Figure 58. Global Adult Vaccine Sales Market Share by Application (2016-2026)
Figure 59. Global Adult Vaccine Revenue Market Share by Application (2016-2026)
Figure 60. Global Adult Vaccine Price by Application (2016-2026) & (USD/MT)
Figure 61. North America Adult Vaccine Sales Market Share by Country (2016-2026)
Figure 62. North America Adult Vaccine Revenue Market Share by Country (2016-2026)
Figure 63. North America Adult Vaccine Sales Market Share by Type (2016-2026)
Figure 64. North America Adult Vaccine Sales Market Share by Application (2016-2026)
Figure 65. Europe Adult Vaccine Sales Market Share by Country (2016-2026)
Figure 66. Europe Adult Vaccine Revenue Market Share by Country (2016-2026)
Figure 67. Europe Adult Vaccine Sales Market Share by Type (2016-2026)
Figure 68. Europe Adult Vaccine Sales Market Share by Application (2016-2026)
Figure 69. Asia-Pacific Adult Vaccine Sales Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Adult Vaccine Revenue Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Adult Vaccine Sales Market Share by Region (2016-2026)
Figure 72. Asia-Pacific Adult Vaccine Sales Market Share by Application (2016-2026)
Figure 73. South America Adult Vaccine Sales Market Share by Country (2016-2026)
Figure 74. South America Adult Vaccine Revenue Market Share by Country (2016-2026)
Figure 75. South America Adult Vaccine Sales Market Share by Type (2016-2026)
Figure 76. South America Adult Vaccine Sales Market Share by Application (2016-2026)
Figure 77. Middle East & Africa Adult Vaccine Sales Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Adult Vaccine Revenue Market Share by Country (2016-2026)
Figure 79. Middle East & Africa Adult Vaccine Sales Market Share by Type (2016-2026)
Figure 80. Middle East & Africa Adult Vaccine Sales Market Share by Application (2016-2026)
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
世界の帯状疱疹ワクチン市場 2021：企業別、地域別、種類・用途別 The Shingles Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, r…- 世界の肺炎球菌多価ワクチン市場 2021：企業別、地域別、種類・用途別 The Pneumococcal Vaccine Polyvalent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界のインフルエンザウイルスベクターワクチン市場規模・現状・予測（2021年-2027年） The virus-sensitive vector vaccine, which is characterized by nasal drip vaccination, is currently undergoing safety and efficacy studies in experimental animals. In 2021, the global Influenza Virus Vector Vaccine market size will be US$ XX million and it is expected to reach US$ XX million by the e…
- 季節性インフルエンザワクチンの世界市場2020年：分析と予測（～2025年） This report describes the global market size of Seasonal Influenza Vaccine from 2015 to 2019 and its CAGR from 2015 to 2019, and also forecasts its market size to the end of 2025 and its CAGR from 2020 to 2025. For geography segment, regional supply, demand, major players, price is presented from 20…
- 世界の小児用ワクチン市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Paediatric Vaccine Market The global Paediatric Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes…